Skip to main content
OpenTrials
Completed

NCT Number: NCT01885975

Personality Profile of Patients With Apical Ballooning Syndrome

The investigators' hypothesis is that patients with apical ballooning syndrome (ABS) will manifest a personality profile that differs than that of a population of similar range of ethnic and socioeconomic status.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients who have suffered with ABS
  • Adults (18 years or older)
  • Able to read English at a 6th grade level (questionnaires are self-administered and written in English)

Exclusion criteria

  • Have withdrawn from the registry
  • Have died

Treatment and study plan

Primary outcomes

  1. Range of personality traits as assessed by the "NEO-PI-3"

    Time frame: Baseline: the traits will be assessed once upon enrollment into the study

    The "NEO PI-3" measures the five major domains of personality, which are:

    • Neuroticism
    • Extraversion
    • Openness
    • Agreeableness
    • Conscientiousness

Sponsors and collaborators

Lead sponsor

Mayo Clinic

Other

Registry information

Official study title

Personality Profile of Patients With Apical Ballooning Syndrome (ABS)

Important dates

Study start
2013
Primary completion
2014
Study completion
2014
First posted
Jun 25, 2013
Registry last updated
Feb 16, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.